Alaa Abd-Elsayed | Neuromidulation | Best Researcher Award

Posted on by sciencefather

Dr. Alaa Abd-Elsayed | Neuromidulation | Best Researcher Award

Dr. Alaa Abd-Elsayed 🇺🇸 is an American board-certified anesthesiologist and pain medicine specialist at the University of Wisconsin-Madison 🏥, recognized for his leadership, groundbreaking research 🔬, and compassionate patient care 💉, with a prolific academic career as a professor, director, and global speaker 🎤, blending clinical excellence, innovation, and education 📚 in pain management, with over two decades of medical service and leadership roles across Egypt 🇪🇬 and the U.S. 🇺🇸, while holding numerous prestigious certifications 🏅, published research, and leadership awards 🏆, he stands as a dedicated pioneer in improving chronic pain therapy 🔥 and anesthesiology practice worldwide 🌍.

Profile

Education 🎓

Dr. Alaa’s academic journey began at Assuit University 🇪🇬, earning his MBBCh 🩺 in 2000 & MPH 🎓 in 2006; postgrad, he trained extensively in the U.S. 🇺🇸, completing internships, anesthesiology residency, and a pain medicine fellowship 🏥 at the University of Cincinnati 🎯, and a Clinical Research Fellowship at Cleveland Clinic 🧪; board-certified in anesthesiology & chronic pain medicine 💊, and a Certified Physician Executive (CPE) 🏆, he capped his academic prowess with an Executive MBA 🎓 in 2023, mastering both medicine & healthcare leadership 🧠, and attending diverse leadership programs 💼 from AAPL, UW Health, and Faulkner University, cementing a strong foundation in clinical care and strategic innovation ⚡.

Experience 👨‍🏫

With over 20 years in medicine 🩺, Dr. Alaa has held roles from intern 👨‍⚕️ in Egypt 🇪🇬 to Associate Professor 📖, First Division Chief, and Medical Director at UW-Madison 🇺🇸; he’s led UW Health Pain Services 🔥, pioneering chronic pain medicine management 💊; his journey spanned positions at Assuit University, Cleveland Clinic, and University of Cincinnati 🏥; he’s served as chief fellow, staff anesthesiologist, researcher 🔬, educator 📚, and leader, combining advanced clinical practice 🏆 with administrative excellence 💼, mentoring future physicians while driving cutting-edge research 🚀 and pain medicine innovations 🌟.

Awards & Recognitions 🏅

Dr. Alaa’s distinguished career is crowned with awards 🌟 like the Raj/Racz Excellence Award 🥇, Physician of the Year 🏅, America’s Top Doctors 👏, Fellow of ASA 🧠, and recognition as a World Expert 🌍 in pain by Expertscape; multiple top research, poster 🖼️, and abstract prizes 🧾 from ASIPP, MARC, ASPN, ASA, INS & WSA 🏆 highlight his prolific contributions, while his books 📚 were ranked among the best in anesthesiology and pain medicine 💊; his research has shaped clinical practices 🌡️ and his leadership has been applauded across national and global stages 🎤, underlining his impact as a clinician, educator, and thought leader 💡.

Research Interests 🔬

Dr. Alaa’s research explores pain management innovation 🔥, neuromodulation ⚡, spinal cord stimulation 🧠, dorsal root ganglion therapies 💉, and anesthesiology outcomes 🧾; he’s passionate about translating bench-to-bedside discoveries 🏥, optimizing patient-centered chronic pain therapies 💊, and advancing perioperative safety 🌡️; his peer-reviewed publications 📚, clinical trials 🧪, and systematic reviews ⚗️ have influenced global practices 🌍, securing his place among top 0.05% scholars worldwide 🏆; his scientific vision combines clinical evidence, bioethics, and real-world health solutions for pain relief and anesthetic care 🧠💡.

Publications 

Jolanta Dorszewska | Neurobiology | Women Researcher Award

Posted on by sciencefather

Dr. Jolanta Dorszewska | Neurobiology | Women Researcher Award

Professor Jolanta Dorszewska is a globally recognized neuroscientist and pharmacologist based at Poznan University of Medical Sciences, Poland 🧠🇵🇱. She leads the Laboratory of Neurobiology, exploring the molecular and genetic basis of neurodegenerative diseases 🧬. With over 35 years of academic experience, her work spans neurochemistry, clinical neurology, and genetic research in Alzheimer’s and Parkinson’s disease 🧪. A prolific author, she has contributed to 80+ research papers, 50+ reviews, and 30+ book chapters 📚. She serves on editorial boards of top neuroscience journals and holds leadership roles in national and international neurological societies 🌍.

Profile

Education 🎓

Prof. Dorszewska earned her M.Sc. in Pharmacy with distinction from Poznan University of Medical Sciences in 1987 🏅. She completed board certifications in Pharmaceutical Analytics (1990 & 1997) and received her Ph.D. in 1996 🧪. In 2004, she qualified as an Associate Professor and achieved full Professorship in 2016 🎓. Her academic growth includes training in medical genetics from 2012 to 2020 🧬. Her education reflects an evolving blend of pharmacy, neurobiology, and genetics, forming the foundation of her current research excellence 💡.

Experience 👨‍🏫

Prof. Dorszewska began as an Assistant in the Dept. of Pharmacy (1987-88), then in Clinical Neurochemistry (1988-96) at PUMS 👩‍🔬. She was a Research Scientist in New York (1999–2000) 🗽 and has led the Laboratory of Neurobiology since 2004 🧠. She became Full Professor in 2022 🏛️. She also lectured at the National High Medical School in Pila (2012–2018) 📖. Her career blends hands-on research, global collaboration, and dedicated academic leadership 📚. She continues to mentor, publish, and drive innovations in neurology and neurochemistry 🚀

Awards & Recognitions 🏅

Awards and Honors:
Prof. Dorszewska is a Local Honorary Member of the 12th World Congress on Controversies in Neurology (2018) 🌐. She has served as Guest Editor for 6 prestigious theme issues and holds editorial roles in top-tier journals like Frontiers in Molecular Neuroscience and Current Alzheimer Research 📘. A section and associate editor for journals across the USA, UK, and Poland 🌍, she’s a key figure in scientific publishing 🖋️. She’s affiliated with the Polish Academy of Sciences and international neurological societies and has co-edited 5 books 📚.

Research Interests 🔬

Research Focus:
Her research spans lipid metabolism in hypoxia 🧫, cerebral sterols 🧠, neurotransmitters (serotonin, dopamine) 🧪, apoptosis in aging and disease (Alzheimer’s, Parkinson’s) 💔, and gene polymorphisms (MTHFR, MAO-B, PARK) 🧬. She investigates homocysteine metabolism, catecholamine pathways, and molecular changes in neurodegeneration 🧠. Since 2009, she’s focused on genetic mutations (PARK, APOE), biomarkers (ASN, microRNAs), and migraine genetics ⚙️. She uses advanced techniques like HPLC, PCR, ELISA, and immunohistochemistry 🔍. Her interdisciplinary work integrates neurobiology, pharmacogenomics, and molecular neuroscience in tackling brain diseases 🚀.

Publications 

  • Genetic variants of ZNF746 and the level of plasma Parkin, PINK1, and ZNF746 proteins in patients with Parkinson’s disease

    IBRO Neuroscience Reports
    2025-06 | Journal article
    DOI: 10.1016/j.ibneur.2025.01.016
    CONTRIBUTORS: Jolanta Dorszewska; Jolanta Florczak-Wyspiańska; Bartosz Słowikowski; Wojciech Owecki; Oliwia Szymanowicz; Ulyana Goutor; Mateusz Dezor; Paweł P. Jagodziński; Wojciech Kozubski

  • Kinesiotherapeutic Possibilities and Molecular Parameters in Multiple Sclerosis

    Sclerosis
    2025-04-03 | Journal article
    DOI: 10.3390/sclerosis3020013
    CONTRIBUTORS: Katarzyna Wiszniewska; Małgorzata Wilk; Małgorzata Wiszniewska; Joanna Poszwa; Oliwia Szymanowicz; Wojciech Kozubski; Jolanta Dorszewsk

  • Unraveling the Role of Proteinopathies in Parasitic Infections

    Biomedicines
    2025-03-03 | Journal article
    DOI: 10.3390/biomedicines13030610
    CONTRIBUTORS: Mikołaj Hurła; Damian Pikor; Natalia Banaszek-Hurła; Alicja Drelichowska; Jolanta Dorszewska; Wojciech Kozubski; Elżbieta Kacprzak; Małgorzata Paul

  • Expression of Neuronal Nicotinic Acetylcholine Receptor and Early Oxidative DNA Damage in Aging Rat Brain—The Effects of Memantine

    International Journal of Molecular Sciences
    2025-02-14 | Journal article
    DOI: 10.3390/ijms26041634
    CONTRIBUTORS: Małgorzata Anna Lewandowska; Agata Różycka; Teresa Grzelak; Bartosz Kempisty; Paweł Piotr Jagodziński; Margarita Lianeri; Jolanta Dorszewska

Ata Jahangir Moshayedi | Brain Stimulation | Best Researcher Award

Posted on by sciencefather

Dr. Ata Jahangir Moshayedi | Brain Stimulation | Best Researcher Award

Dr. Ata Jahangir Moshayedi is an Associate Professor at Jiangxi University of Science and Technology 🇨🇳 with a PhD in Electronic Science 🎓 from Savitribai Phule Pune University 🇮🇳. He is a prolific academic 🧠 with over 90 publications 📚, three authored books 📖, two patents 🧾, and nine copyrights 📝. A distinguished member of IEEE ⚡, ACM 💻, Instrument Society of India 🧪, and Speed Society of India 🚀, he contributes to editorial boards 🗞️ and international conferences 🌐. His interdisciplinary expertise bridges robotics 🤖, AI 🤖, VR 🕶️, and embedded systems 🔧, driving innovation in education and technology 🚀.

Profile

Education 🎓

Dr. Moshayedi earned his PhD in Electronic Science from Savitribai Phule Pune University 🇮🇳, specializing in robotics and automation 🤖. His educational path is deeply rooted in multidisciplinary technologies like embedded systems 🔧, machine vision 👁️, and AI 🧠. With academic training grounded in both theory 📘 and application 🛠️, he cultivated expertise across digital systems 💡 and bio-inspired robots 🦾. He integrates engineering principles with computer science 💻 to develop cutting-edge innovations in virtual and intelligent systems 🌍. His educational achievements laid the foundation for his impactful career in academic research and mentoring 📈.

Experience 👨‍🏫

Dr. Moshayedi has served as Associate Professor at Jiangxi University of Science and Technology 🇨🇳 since 2018. He leads modules in Robotics 🤖, Embedded Systems 💻, and Digital Image Processing 📷. He supervises UG and PG research 🧪, formulates grant proposals 💡, and serves as a module leader and tutor across advanced computer engineering courses 🧑‍🎓. His role includes designing learning materials 📘, aligning curriculum with accreditation standards 🎯, and evaluating student performance 🎓. He has extensive teaching experience in C/C++ programming 💾, algorithm analysis 📊, and mobile app programming 📱, ensuring comprehensive academic development.

Awards & Recognitions 🏅

🥇2024: Best Mentor, Jiangxi University 👨‍🏫 | 🏅2022: Book Award (Unity in Embedded System Design and Robotics) 📖 | 🥉2022: 3rd National & 1st Provincial Prize, Handy Pipe Detector, China Computer Design Competition 🛠️ | 🥉2021: 3rd National & 2nd Provincial, PEA Project (Pandemic Exam Assistant) 🧪 | 🏆2021: Innovation Award, Iran National Festival 🌍 | 🥉2021: 3rd National & 2nd Provincial, RDK Cloud Robot, Intelligent Service Robot Challenge ☁️🤖 — All reflecting his excellence in guiding innovation, mentoring students 👨‍🎓, and advancing global tech competitions 🌐.

Research Interests 🔬

Dr. Moshayedi’s research integrates robotics 🤖, AI 🧠, and embedded systems 🔧. His work on bio-inspired robots 🐜, mobile robot olfaction 👃, and sensor modeling 🧪 explores intelligent perception and environmental interaction 🌫️. He develops machine vision-based systems 👁️, virtual reality environments 🕶️, and smart embedded architectures 🖥️. His focus on plume tracking 🌬️ and cloud robotics ☁️ brings autonomous systems closer to real-world application. Merging theory and practice 🔍, his research propels innovation across intelligent systems, cyber-physical interaction 🌐, and real-time automation, making significant strides in modern engineering and applied AI 🤖.

Publications 

Yuanyuan Li | Movement Disorder | Best Researcher Award

Posted on by sciencefather

Dr. Yuanyuan Li | Movement Disorder | Best Researcher Award

🧠 Dr. Yuanyuan Li is a dedicated neurologist and researcher specializing in neurodegenerative diseases, particularly Parkinson’s disease and REM sleep behavior disorder. She obtained her Ph.D. in Neurology from Shanghai Jiao Tong University School of Medicine and has been actively involved in cutting-edge research at Ruijin Hospital’s Department of Neurology. As a project leader, she has explored the role of α-synuclein in dopaminergic neurons, investigating its transport pathways and impact on cell viability. Dr. Li has authored multiple high-impact publications in renowned journals such as Neurology and J Neuroinflammation. Her work has contributed significantly to understanding the early biomarkers of neurodegenerative disorders. She has received prestigious awards, including the National Scholarship for Doctoral Students and the Outstanding Graduate Award from Shanghai Jiao Tong University. With numerous conference presentations and accolades, Dr. Li continues to drive forward advancements in neurodegenerative disease research. ✨📚

Profile

Education 🎓

🎓 Dr. Yuanyuan Li completed her Ph.D. in Neurology at Shanghai Jiao Tong University School of Medicine, where she focused on neurodegenerative diseases, particularly Parkinson’s disease and REM sleep behavior disorder. Her doctoral research emphasized the role of α-synuclein in dopaminergic neurons, uncovering its impact on neurodegeneration. Throughout her academic journey, Dr. Li consistently demonstrated excellence, earning the First-Class Academic Scholarship and the Meritorious Student Award. She was recognized as an Outstanding Graduate and received the prestigious National Scholarship for Doctoral Students. Beyond coursework, she actively engaged in translational research, bridging laboratory findings with clinical applications. Her education has provided a strong foundation in neurobiology, molecular neuroscience, and clinical neurology. With a passion for uncovering early biomarkers of neurodegeneration, Dr. Li’s educational background has shaped her into a leading researcher in the field. 📖🧬

Experience 👨‍🏫

Dr. Yuanyuan Li has extensive research experience at Ruijin Hospital’s Department of Neurology, affiliated with Shanghai Jiao Tong University School of Medicine. As a principal investigator, she led the Shanghai Jiao Tong University Doctoral Innovation Fund project, studying α-synuclein’s transport mechanisms in dopaminergic neurons and its effects on cell viability. Her expertise spans biomarker discovery, neuroinflammation, and disease progression in neurodegenerative disorders. She has collaborated on numerous high-impact studies published in Neurology, J Neuroinflammation, and NPJ Parkinson’s Disease. Dr. Li has also presented her findings at major conferences, including the National Neurology Conference and the Oriental Neurology Conference. Her experience in both basic and clinical research allows her to bridge the gap between laboratory discoveries and patient applications, advancing diagnostic and therapeutic strategies for Parkinson’s disease and related disorders. 🏥🧠

Awards & Recognitions 🏅

Dr. Yuanyuan Li has received numerous prestigious awards for her contributions to neurology and neuroscience research. She was awarded the National Scholarship for Doctoral Students, recognizing her academic excellence and groundbreaking research. She also received the Outstanding Graduate Award and the Meritorious Student Award from Shanghai Jiao Tong University. Her outstanding academic performance earned her the First-Class Academic Scholarship, demonstrating her dedication to advancing neurological research. Dr. Li has been recognized for her contributions at major conferences, winning the “Excellent Paper Presentation” award at the Oriental Neurology Conference. Additionally, she secured First Prize for Poster Presentation at the “Bo Ji Yi Yuan” Academic Forum. Her accolades reflect her commitment to advancing our understanding of neurodegenerative diseases, particularly Parkinson’s disease. These honors highlight her as a rising star in the field of neurology. 🏅📜

Research Interests 🔬

🧪 Dr. Yuanyuan Li’s research focuses on neurodegenerative diseases, with an emphasis on Parkinson’s disease, REM sleep behavior disorder (RBD), and α-synuclein pathology. Her work explores the molecular mechanisms driving these disorders, particularly the role of α-synuclein in dopaminergic neurons, its transport pathways, and its impact on cell viability. She has also investigated immune biomarkers, neuroinflammation, and genetic variants associated with Parkinson’s progression. Dr. Li’s studies have contributed to identifying predictive markers for early-stage neurodegenerative diseases, aiding in early diagnosis and potential therapeutic interventions. Through her publications in top journals like Neurology, J Neuroinflammation, and NPJ Parkinson’s Disease, she has advanced knowledge in the field. Her work integrates clinical and experimental neuroscience, bridging gaps between laboratory findings and real-world applications. Dr. Li’s research continues to shape the understanding of neurodegenerative disorders and their early detection. 🧬🔍

 

4Publications 

  • Gene Polymorphisms of Parkinson’s Disease Risk Locus and Idiopathic REM Sleep Behavior Disorder

    Biomedicines
    2025-03-24 | Journal article
    DOI: 10.3390/biomedicines13040788
    CONTRIBUTORS: Min Zhong; Yang Jiao; Aonan Zhao; Mengyue Niu; Jinjun Ran; Jun Liu; Yuanyuan Li

  • Understanding Causal Relationships Between Imaging-Derived Phenotypes and Parkinson’s Disease: A Mendelian Randomization and Observational Study

    Biomedicines
    2025-03-18 | Journal article
    DOI: 10.3390/biomedicines13030747
    CONTRIBUTORS: Yichi Zhang; Min Zhong; Zhao Yang; Xiaojin Wang; Zhongxun Dong; Liche Zhou; Qianyi Yin; Bingshun Wang; Jun Liu; Yuanyuan Li et al.

  • Understanding Causal Relationships between Imaging-Derived Phenotypes and Parkinson’s Disease: A Mendelian Randomization and Observational Study

    2025-02-05 | Preprint
    DOI: 10.20944/preprints202502.0350.v1
    CONTRIBUTORS: Yichi Zhang; Min Zhong; Zhao Yang; Xiaojin Wang; Zhongxun Dong; Liche Zhou; Qianyi Yin; Bingshun Wang; Jun Liu; Yuanyuan Li et al.

  • Network disruption based on multi-modal EEG-MRI in α-synucleinopathies

    Frontiers in Neurology
    2024 | Journal article
    DOI: 10.3389/FNEUR.2024.1442851
    WOSUID: WOS:001304283700001
    CONTRIBUTORS: Wang, Chunyi; Hu, Jiajia; Li, Puyu; Zhang, Ming; Zhou, Liche; Luo, Ningdi; Zhu, Xue; Yin, Qianyi; Zhong, Min; Zhou, Xinyi et al.

Elsa Pittaras | Neuroscience | Women Researcher Award

Posted on by sciencefather

Dr. Elsa Pittaras | Neuroscience | Women Researcher Award

Elsa Pittaras is a Basic Life Research Scientist at Stanford University, specializing in neuroscience, cognition, and sleep research. With expertise in molecular biology, neuroanatomy, pharmacology, and behavior, she has extensively studied decision-making processes in mice. Her research has contributed significantly to understanding sleep deprivation’s effects on cognition and memory in Down Syndrome and Alzheimer’s disease models. She has published multiple papers as both first and last author, showcasing her leadership in neuroscience. Elsa’s goal is to advance research on mood disorders, cognition, and neurochemistry, aspiring to become an independent researcher in the U.S. 🇺🇸🔬🧠

Profile

Education 🎓

Elsa Pittaras earned a B.S. in Physiology from the University of Caen (2010), an M.S. in Neuroscience from the University of Paris Sud and ENS Cachan (2012), and a Ph.D. in Neuroscience from Neuro-PSI and the Biomedical Research Unit of the French Army (2016). Her multidisciplinary foundation in biology, physics, chemistry, and mathematics from Châtelet, Douai (2009) laid the groundwork for her neuroscience expertise. Throughout her education, she focused on decision-making, sleep deprivation, and neurochemical mechanisms in cognition. 🧠📚🎓

Experience 👨‍🏫

Elsa Pittaras has been a Basic Life Research Scientist at Stanford University since 2022, focusing on cognitive enhancement in Down Syndrome and Alzheimer’s disease models. She was a Postdoctoral Fellow at Stanford (2017-2022), investigating sleep and circadian rhythms’ effects on memory. Previously, she conducted research at the Biomedical Research Unit of the French Army (2016-2017) and completed her Ph.D. at Neuro-PSI. Her career includes internships in neuroscience at Neuro-PSI (2011-2012) and clinical observations at CHU Caen (2010). 🏛️🧬🧪

Research Interests 🔬

Elsa’s research explores decision-making, memory, and sleep in neurodevelopmental disorders. She pioneered the Mouse Gambling Task, revealing individual decision-making strategies. Her Ph.D. identified neurochemical markers of decision-making behaviors and the effects of sleep deprivation. At Stanford, she investigates sleep’s impact on cognition in Down Syndrome and Alzheimer’s models, aiming to improve memory and sleep quality through pharmacological interventions. Her work bridges behavioral neuroscience with neurochemistry to enhance cognitive function. 🧠💡🛌

Awards & Recognitions 🏅

Elsa has received prestigious grants, including the Jerome Lejeune Research Grants (2019, 2020), the Fyssen Foundation Research Grant (2017), and travel awards for conferences such as T21RS (2021) and Advances in Sleep and Circadian Science (2019). She was also recognized by the French Society for Research and Sleep Medicine (2014) and received a European Neuroscience Federation travel award (2016). 🏅

Publications 

  • Selectively Blocking Small Conductance Ca2+-Activated K+ Channels Improves Cognition in Aged Mice.

  • Short-term γ-aminobutyric acid antagonist treatment improves long-term sleep quality, memory, and decision-making in a Down syndrome mouse model

  • Behavioral and Neuronal Characterizations, across Ages, of the TgSwDI Mouse Model of Alzheimer’s Disease.

  • Inter-individual differences in cognitive tasks: focusing on the shaping of decision-making strategies

  • Handling, task complexity, time-of-day, and sleep deprivation as dynamic modulators of recognition memory in mice

  • Enhancing sleep after training improves memory in down syndrome model mice

 

said Pournaghash-tehrani | Neuroscience | Best Faculty Award

Posted on by sciencefather

Dr. said Pournaghash-tehrani | Neuroscience | Best Faculty Award

 

Profile

  • Googlescholar
  • Researchgate

Education

Said Pournaghash-Tehrani earned his Doctor of Philosophy in Psychology in 1993 from The American University in Washington, D.C., where he also completed his Master of Arts in Psychology in 1990. He holds a Bachelor of Science in Distributive Science from the same institution, which he obtained in 1986. Fluent in English and German, he also has familiarity with French. He can be reached via email at spournaghash@yahoo.com or by telephone at 011-98-09122074388.

Work experience
  • Said Pournaghash-Tehrani has extensive academic and research experience in psychology. He served as a Research Associate in 2001 at the Department of Pharmacology and Experimental Therapeutics, Loyola University’s Stritch School of Medicine in Chicago, Illinois. In 2002, he took a sabbatical as a researcher at the Department of Psychology, Carleton University in Ottawa, Canada, focusing on cross-cultural studies related to Iranian attitudes towards the West. Since 2002, he has been an Assistant Professor in the Department of Psychology at Tehran University, having previously held the same position at Azzahra University in Tehran from 1996 to 2001. Additionally, he was a member of the Scientific Council on Energy and Economic Studies at the Institute for International and Political Studies (IPIS) from 1998 to 2000, where he also worked as a political researcher. His early academic career included serving as a Teaching and Research Assistant at The American University’s Department of Psychology from 1987 to 1990, where he contributed to courses such as Introduction to Psychology, Neuroscience Seminar, Psychopharmacology, Neuropsychology, Biological Basis of Behavior, and Learning and Behavior.

Books

–Fundamentals of Clinical Psychopharmacology, (2007); Samt Publications
-Drugs and Behavior, (2004); Samt Publications.
-Physiological Psychology, Tehran University Publication.
-Intimacy; Alzahra University Publication.
-Theories of Addiction, Alzahra University Publication.

Conference Presentations

Said Pournaghash-Tehrani has contributed extensively to neuroscience and psychology research, presenting his findings at prestigious conferences such as the Society for Neuroscience and the Eastern Psychological Association. His work has focused on drug discrimination learning, conditioned taste aversion, and the effects of opioids and their antagonists. In 1987, he co-authored studies assessing the discriminative stimulus properties of naloxone and the failure of cholecystokinin to counteract morphine sulfate’s effects. His later research explored the antagonism of morphine stimuli, the role of buprenorphine in opiate-naive and dependent animals, and the impact of RO15-4513 on ethanol-induced taste aversion. He has collaborated with notable researchers, including A.L. Riley, contributing to investigations on diazepam exposure and behavioral toxicology. His presentations in New Orleans, Washington, D.C., Boston, and other major research venues highlight his significant role in advancing psychopharmacology and behavioral neuroscience.

Publication